Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ekkehard Genth

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Arthritis Research & Therapy|March 6, 2009
High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacyNicolas Hunzelmann, Pia Moinzadeh, Ekkehard Genth, et al.
Arthritis Research|March 7, 2002
Autoantibodies directed to novel components of the PM/Scl complex, the human exosomeRick Brouwer, Wilma T M Vree Egberts, Gerald J D Hengstman, et al.
Arthritis Research & Therapy|October 25, 2011
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical featuresRudolf Mierau, Pia Moinzadeh, Gabriela Riemekasten, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosisPia Moinzadeh, Elisabeth Aberer, Keihan Ahmadi-Simab, et al.
The Journal of Rheumatology|November 17, 2015
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 PatientsPia Moinzadeh, Gabriela Riemekasten, Elise Siegert, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Arthritis Research & Therapy|March 6, 2009
High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacyNicolas Hunzelmann, Pia Moinzadeh, Ekkehard Genth, et al.
Arthritis Research|March 7, 2002
Autoantibodies directed to novel components of the PM/Scl complex, the human exosomeRick Brouwer, Wilma T M Vree Egberts, Gerald J D Hengstman, et al.
Arthritis Research & Therapy|October 25, 2011
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical featuresRudolf Mierau, Pia Moinzadeh, Gabriela Riemekasten, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosisPia Moinzadeh, Elisabeth Aberer, Keihan Ahmadi-Simab, et al.
The Journal of Rheumatology|November 17, 2015
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 PatientsPia Moinzadeh, Gabriela Riemekasten, Elise Siegert, et al.
Pageof 2